CATX icon

Perspective Therapeutics

112 hedge funds and large institutions have $96.4M invested in Perspective Therapeutics in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

17% less funds holding

Funds holding: 135112 (-23)

36% less capital invested

Capital invested by funds: $151M → $96.4M (-$54.3M)

64% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 36

Holders
112
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$92K
Puts
$22K
Net Calls
Net Calls Change

Top Buyers

1 +$2.08M
2 +$1.97M
3 +$1.11M
4
Morgan Stanley
Morgan Stanley
New York
+$884K
5
Marshall Wace
Marshall Wace
United Kingdom
+$699K

Top Sellers

1 -$3.8M
2 -$2.53M
3 -$1.28M
4
APM
Avidity Partners Management
Texas
-$1.06M
5
Walleye Capital
Walleye Capital
New York
-$930K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$645K
27
$643K
28
$523K
29
$429K
30
$405K
31
$348K
32
$339K
33
$295K
34
$288K
35
$266K
36
$260K
37
$253K
38
$245K
39
$230K
40
$213K
41
$213K
42
$209K
43
$205K
44
$192K
45
$182K
46
$158K
47
$130K
48
$123K
49
$110K
50
$106K